Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-19T08:29:43.681Z Has data issue: false hasContentIssue false
  • English
  • Français

Footwear Exchange Has No Influence on the Incidence of Febrile Neutropenia in Patients Undergoing Chemotherapy for Hematologic Malignancies

Published online by Cambridge University Press:  02 January 2015

Hiroyuki Sugahara ,
Masao Mizuki ,
Sayoko Matsumae ,
Yoshiko Nabetani ,
Motoko Kikuchi  and
Yuzuru Kanakura
Hiroyuki Sugahara
Affiliation:
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Masao Mizuki*
Affiliation:
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
Sayoko Matsumae
Affiliation:
Hematology Unit, Osaka University Hospital, Suita, Japan
Yoshiko Nabetani
Affiliation:
Hematology Unit, Osaka University Hospital, Suita, Japan
Motoko Kikuchi
Affiliation:
Hematology Unit, Osaka University Hospital, Suita, Japan
Yuzuru Kanakura
Affiliation:
Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
*
Hematology and Oncology, Osaka University Graduate School of Medicine, C9, 2-2 Yamada-oka, Suita, 565-0871, Japan
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To determine whether footwear exchange affects the incidence of febrile neutropenia among patients undergoing chemotherapy for hematologic malignancies.

Design:

Open trial with historical comparison.

Setting:

The 12-bed high-efficiency particulate air-fil-tered hematology unit at Osaka University Hospital, Suita, Japan.

Patients:

Those with hematologic malignancies who underwent chemotherapy from January 1997 through January 2003. Footwear exchange was discontinued in January 2000.

Methods:

The surveillance system was based on the National Nosocomial Infections Surveillance System of the Centers for Disease Control and Prevention. Rates of febrile neutropenia were calculated for neutropenic patient-days (ie, days with neutropenia < 500/μL).

Results:

From January 1997 through December 1999 and from February 2000 through January 2003, 58 and 54 patients endured 237 and 184 neutropenic periods following chemotherapy, and their total neutropenic days were 3,123 and 2,503, respectively. They showed episodes of febrile neutropenia 89 and 68 times, respectively. Infection rates were 28.5 and 27.2 per 1,000 neutropenic patient-days (P = .83), respectively.

Conclusion:

The incidence of febrile neutropenia was not affected by footwear exchange. In hematology units, changing shoes does not appear to affect the rate of infections during neutropenic periods.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 25 , Issue 1 , January 2004 , pp. 51 - 54
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Chanock, SJ, Pizzo, PA. Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects. Semin Oncal 1997;24:132–140.Google ScholarPubMed
2.Anaissie, EJ, Vadhan-Raj, S. Is it time to redefine the management of febrile neutropenia in cancer patients? Am J Med 1995;98:221–223.CrossRefGoogle ScholarPubMed
3.Aksu, G, Ruhi, MZ, Akan, H, et al.Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Boue Marrow Transplant 2001;27:201–205.CrossRefGoogle ScholarPubMed
4.Oren, I, Haddad, N, Finkelstein, R, Rowe, JM. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Am J Hematol 2001;66:257–262.CrossRefGoogle ScholarPubMed
5.Hambraeus, A, Malmborg, AS. The influence of different footwear on floor contamination. Scand J Infect Dis 1979;11:243–246.CrossRefGoogle ScholarPubMed
6.Copp, G, Slezak, L, Dudley, N, Mailhot, CB. Footwear practices and operating room contamination. Nurs Res 1987;36:366–369.CrossRefGoogle ScholarPubMed
7.Maki, DG, Alvarado, CJ, Hassemer, CA, Zilz, MA. Relation of the inanimate hospital environment to endemie nosocomial infection. N Engl J Med 1982;307:1562–1566.CrossRefGoogle Scholar
8.Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128–140.CrossRefGoogle ScholarPubMed
9.Engelhart, S, Glasmacher, A, Exner, M, Kramer, MH. Surveillance for nosocomial infections and fever of unknown origin among adult hematology-oncology patients. Infect Control Hosp Epidemiol 2002;23:244–248.CrossRefGoogle ScholarPubMed
10.Gruppo Italiano malattie ematologiche maligne dell'adult. Prevention of bacterial infection in neutropenic patients with hematologie malignancies: a randomized, multicenter trial comparing norfloxacin with ciprofloxacin. Ann Intern Med 1991,115:7–12.CrossRefGoogle Scholar
11.Shinjo, K, Takeshita, A, Yanagi, M, et al.Efficacy of Shinki bioclean room for preventing infection in neutropenic patients. J Adv Nurs 2002;37:227–233.CrossRefGoogle ScholarPubMed
12.Auner, HW, Sill, H, Mulabecirovic, A, Linkesch, W, Krause, R. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 2002;81:374–377.Google ScholarPubMed
13.Pizzo, PA. The value of protective isolation in preventing nosocomial infections in high risk patients. Am J Med 1981;70:631–637.CrossRefGoogle ScholarPubMed
14.Kenny, H, Lawson, E. The efficacy of cotton cover gowns in reducing infection in nursing neutropenic patients: an evidence-based study. Int J Nurs Pract 2000;6:135–139.CrossRefGoogle ScholarPubMed
15.Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation: guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6:659–734.Google Scholar
16.Loo, VG, Bertrand, C, Dixon, C, et al.Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 1996;17:360–364.CrossRefGoogle Scholar